The PE Ratio as of November 2024 (TTM) for Bavarian Nordic A/S (BVNKF) is 13.86

According to Bavarian Nordic A/S’s latest financial reports and current stock price. The company's current PE Ratio is 13.86. This represents a change of -609.97% compared to the average of -2.72 of the last 4 quarters.

Bavarian Nordic A/S (BVNKF) Historical PE Ratio (quarterly & annually)

How has BVNKF PE Ratio performed in the past?

The mean historical PE Ratio of Bavarian Nordic A/S over the last ten years is 75.85. The current 13.86 PE Ratio has changed 1.73% with respect to the historical average. Over the past ten years (40 quarters), BVNKF's PE Ratio was at its highest in in the December 2015 quarter at 1.08K. The PE Ratio was at its lowest in in the March 2017 quarter at -560.47.

Bavarian Nordic A/S (BVNKF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bavarian Nordic A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bavarian Nordic A/S (BVNKF) Average PE Ratio

How has BVNKF PE Ratio performed in the past?

The current PE Ratio of Bavarian Nordic A/S (BVNKF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Bavarian Nordic A/S (BVNKF) PE Ratio vs. Peers

How is BVNKF’s PE Ratio compared to its peers?

Bavarian Nordic A/S’s PE Ratio is greater than AN2 Therapeutics, Inc. (-0.66), greater than Miromatrix Medical Inc. (-7.13), greater than Inhibikase Therapeutics, Inc. (-1.05), greater than PMV Pharmaceuticals, Inc. (-1.61), greater than Anebulo Pharmaceuticals, Inc. (-4.78), greater than Molecular Partners AG (-2.50), greater than Mineralys Therapeutics, Inc. (-4.06), greater than Pharvaris N.V. (-8.69), greater than PepGen Inc. (-1.65), greater than Edgewise Therapeutics, Inc. (-24.30), greater than Rallybio Corporation (-0.68), greater than Opthea Limited (-1.15), greater than Replimune Group, Inc. (-5.51), greater than Nuvalent, Inc. (-27.80), greater than Ventyx Biosciences, Inc. (-0.86), greater than Ascendis Pharma A/S (-16.63), less than United Therapeutics Corporation (14.97), greater than Aura Biosciences, Inc. (-5.34), greater than Axcella Health Inc. (-3.07), greater than H-CYTE, Inc. (-0.02), greater than Antibe Therapeutics Inc. (-1.06),

Build a custom stock screener for Bavarian Nordic A/S (BVNKF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bavarian Nordic A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bavarian Nordic A/S (BVNKF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bavarian Nordic A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.